In Episode 2 of our Summer Series, we explore non-opioid pain management products, separate reimbursement opportunities, and evolving payment methodologies affecting cataract and surgical care. 

(8:20) We are joined by Jill Spiegel and Anthony Francica, Field Reimbursement Directors with Ocular Therapeutix, Inc.

PDF of Podcast
Dextenza® Full Prescribing Information

This summer, Ophthalmology Reimbursed is taking a deep dive into one of the most important and often misunderstood areas of ophthalmology reimbursement. Join us for our three-part podcast series: Beyond the Bundle: Understanding Separate Reimbursement for Drugs, Devices, and Tissues in Ophthalmology

As innovation continues to reshape ophthalmic care, practices are navigating increasingly complex reimbursement pathways for drugs, devices, biologics, and tissues that may qualify for separate payment outside traditional bundled reimbursement models.

Throughout this series, our consultants will discuss the opportunities, challenges, and compliance considerations surrounding these payment methodologies and how they impact physician practices, ambulatory surgery centers, and hospital outpatient departments.

Read the transcript here